Iron deficiency in chronic heart failure: an international pooled analysis
Related Experiment Videos
Ijsbrand T Klip1, Josep Comin-Colet, Adriaan A Voors
1Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Insights
Iron deficiency is common in heart failure patients and predicts mortality. Addressing iron deficiency may improve outcomes, showing greater predictive power than anemia alone.
Area of Science:
- Cardiology
- Hematology
- Internal Medicine
Background:
- Iron deficiency (ID) is an emerging concern in chronic heart failure (HF).
- The prevalence, predictors, and prognostic impact of ID in chronic HF remain incompletely understood.
- ID presents a potential therapeutic target in HF management.
Purpose of the Study:
- To investigate the prevalence, clinical associates, and prognostic consequences of iron deficiency in patients with chronic heart failure.
- To compare the predictive power of iron deficiency versus anemia for mortality in this population.
Main Methods:
- An international pooled cohort of 1,506 patients with chronic HF was analyzed.
- Iron deficiency was defined by ferritin and transferrin saturation levels.
- Prognostic outcomes, including mortality, were assessed over a median follow-up of 1.92 years.
Main Results:
- Iron deficiency was present in 50% of patients, more common in anemic individuals.
- Predictors of ID included higher NYHA class, elevated NT-proBNP, lower MCV, and female sex.
- ID, but not anemia, was a strong independent predictor of mortality (HR 1.42, P = .002) and improved risk classification.
Conclusions:
- Iron deficiency is highly prevalent in chronic heart failure patients.
- ID is associated with disease severity and is a significant independent predictor of mortality.
- Iron deficiency demonstrates greater prognostic value than anemia in chronic heart failure.
Background:
Iron deficiency (ID) is an emerging problem in patients with chronic heart failure (HF) and can be a potential therapeutic target. However, not much is known about the prevalence, predictors, and prognosis of ID in patients with chronic HF.
Methods:
In an international pooled cohort comprising 1,506 patients with chronic HF, we studied the clinical associates of ID and its prognostic consequences.
Results:
Iron deficiency (defined as a ferritin level <100 μg/L or ferritin 100-299 μg/L with a transferrin saturation <20%) was present in 753 patients (50%). Anemic patients were more often iron deficient than nonanemic patients (61.2% vs 45.6%, P < .001). Other independent predictors of ID were higher New York Heart Association class, higher N-terminal pro-brain-type natriuretic peptide levels, lower mean corpuscular volume levels, and female sex (all P < .05). During follow-up (median 1.92 years, interquartile range 1.18-3.26 years), 440 patients died (29.2%). Kaplan-Meier survival analysis revealed ID as a strong predictor for mortality (log rank χ(2) 10.2, P = .001). In multivariable hazard models, ID (but not anemia) remained a strong and independent predictor of mortality (hazard ratio 1.42, 95% confidence interval 1.14-1.77, P = .002). Finally, the presence of ID significantly enhanced risk classification and integrated discrimination improvement when added to a prediction model with established risk factors.
Conclusions:
Iron deficiency is common in patients with chronic HF, relates to disease severity, and is a strong and independent predictor of outcome. In this study, ID appears to have greater predictive power than anemia.
Related Concept Videos
Heart Failure II: Pathophysiology
Heart Failure I: Introduction
Heart Failure III: Clinical Manifestations
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure VII: Nursing Interventions
Heart Failure VI: Adjunct Therapies